SCM
BLCM

Sio Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Sio Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,751
Closed -$58K – 107
2020
Q2 		$58K Sell
7,751
-4,521
-37% -$30.8K 0.02% 77
2020
Q1 		$58K Buy
+12,272
New +$132K 0.02% 68

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sio Capital Management's BLCM Position: Q3 2020 in Review

Sio Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2020, closing a stake of 7,751 shares — an estimated $58K sold.

Sio Capital Management first reported a position in BLCM in Q1 2020 and held it in 2 quarters. The position peaked at $58K in Q2 2020. 22 funds tracked by Wall St. Rank hold BLCM as of Q3 2020.

  • Sio Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Sio Capital Management sold 7,751 Bellicum Pharmaceuticals, Inc. shares in Q3 2020, an estimated $58K.
  • Sio Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
  • Sio Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $58K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2020.

Based on Sio Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.